The most obvious implications of HFE as a negative regulator/inhibitor of MHC I antigen presentation and CD8+ lymphocyte activation are related to the immune response during infections, cancer immune surveillance, and autoimmunity. The gene discussed is HFE; the disease is Autoimmunity.